DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Database

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
1–19 of 19 · RecoveryClear filters
  1. 001

    BPC-157

    A synthetic 15-amino acid peptide whose sequence is derived from a protein described in human gastric juice; it is not FDA approved. In rat and cell studies…

    Recovery · In Clinical Trials · Subcutaneous injection, Oral

    Awaiting FDA
  2. 002

    TB-500 (Thymosin Beta-4)

    Thymosin Beta-4 (Tβ4) is a 43-amino acid actin-sequestering protein involved in cell migration and tissue repair. Products sold as TB-500 have been found to…

    Recovery · Research Phase · Subcutaneous injection

    Awaiting FDA
  3. 003

    GHK-Cu

    A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine, with levels that decline with age. In…

    Recovery · In Clinical Trials · Topical, Subcutaneous injection

    No lawful pathway
  4. 004

    DSIP (Delta Sleep-Inducing Peptide)

    A nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1977 from the cerebral venous blood of sleeping rabbits and initially proposed as a…

    Recovery · Investigational · Subcutaneous injection, Intravenous, Intranasal

    No lawful pathway
  5. 005

    Pentosan Polysulfate (Elmiron)

    A semi-synthetic sulfated polysaccharide (not a peptide) derived from beechwood hemicellulose, with structural similarity to glycosaminoglycans and heparin.…

    Recovery · FDA Approved · Oral

    FDA-approved
  6. 006

    Pentadeca Arginate (PDA)

    Pentadeca Arginate (PDA) is a name used by compounding pharmacies and peptide suppliers for a synthetic 15-amino acid peptide, commonly marketed as a variant…

    Recovery · Research Phase · Subcutaneous injection, Topical

    No lawful pathway
  7. 007

    Thymosin Beta-4 Fragment (TB4-Frag)

    Thymosin Beta-4 fragments are short active segments of the 43-amino acid protein thymosin beta-4. The best studied are the N-terminal tetrapeptide Ac-SDKP…

    Recovery · Research Phase · Subcutaneous injection, Topical

    No lawful pathway
  8. 008

    Cathelicidin LL-37 Fragments

    Cathelicidin LL-37 fragments are truncated or modified sequences derived from the human antimicrobial peptide LL-37, which is a 37-amino acid cleavage product…

    Recovery · Investigational · Topical, Subcutaneous injection

    No lawful pathway
  9. 009

    FGL Peptide

    FGL (FG loop) peptide is a synthetic 15-amino acid peptide corresponding to the binding site of the neural cell adhesion molecule (NCAM) for fibroblast growth…

    Recovery · Investigational · Subcutaneous injection, Intranasal

    No lawful pathway
  10. 010

    GHK (Glycyl-Histidyl-Lysine)

    GHK is a naturally occurring tripeptide (glycyl-histidyl-lysine) with high affinity for copper ions, forming the GHK-Cu complex. It is present in human plasma…

    Recovery · In Clinical Trials · Topical, Subcutaneous injection

    No lawful pathway
  11. 011

    Matrikine Peptides

    Matrikine peptides are bioactive fragments released from extracellular matrix proteins during tissue remodeling or injury. These sequences, derived from…

    Recovery · Research Phase · Topical, Subcutaneous injection

    No lawful pathway
  12. 012

    AHK-Cu (Copper Tripeptide-3)

    AHK-Cu is a synthetic copper-binding tripeptide consisting of alanine-histidine-lysine complexed with copper ions. It is structurally similar to GHK-Cu but…

    Recovery · Research Phase · Topical

    No lawful pathway
  13. 013

    Body Protection Compound (BPC) Variants

    BPC-157 is a 15-amino acid peptide representing a partial sequence of body protection compound, a protein isolated from human gastric juice. It is proposed to…

    Recovery · In Clinical Trials · Subcutaneous injection, Oral

    No lawful pathway
  14. 014

    Collagen Tripeptide F (CTP-F)

    Collagen Tripeptide F is a commercial collagen tripeptide ingredient; collagen tripeptide preparations are rich in small peptides such as Gly-Pro-Hyp and are…

    Recovery · Investigational · Topical, Subcutaneous injection

    No lawful pathway
  15. 015

    Sinapultide (KL4 Surfactant)

    Sinapultide (KL4) is a synthetic 21-amino acid peptide that mimics surfactant protein B, a critical component of pulmonary surfactant. Combined with…

    Recovery · FDA Approved · Intratracheal instillation

    FDA-approved
  16. 016

    Chrysalin (TP508)

    Chrysalin, also known as TP508 or rusalatide acetate, is a 23-amino acid synthetic peptide representing a portion of the receptor-binding domain of human…

    Recovery · Investigational · Topical, Subcutaneous injection

    No lawful pathway
  17. 017

    Nexagon (Gap Junction Peptide)

    Nexagon (lufepirsen) is not a peptide: it is a connexin43-specific antisense oligodeoxynucleotide, a short strand of DNA that transiently blocks production of…

    Recovery · In Clinical Trials · Topical

    No lawful pathway
  18. 018

    OP-1 / BMP-7

    OP-1, or osteogenic protein-1, is the recombinant form of bone morphogenetic protein-7 (BMP-7), a member of the transforming growth factor-beta superfamily.…

    Recovery · FDA Approved · Implantation at surgical site

    FDA-approved
  19. 019

    Dalargin

    Dalargin is a synthetic hexapeptide analogue of leucine-enkephalin, D-Ala2, Leu5, Arg6-enkephalin. It acts on opioid receptors, with different studies…

    Recovery · In Clinical Trials · Intravenous, Intramuscular injection

    No lawful pathway

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.